Neurology 2000;54:914-920
© 2000 American Academy of Neurology
Articles
Brain volume in children with neurofibromatosis type 1
Relation to neuropsychological status
B. D. Moore, III, PhD,
J. M. Slopis, MD,
E. F. Jackson, PhD,
A. E. De Winter, PhD and
N. E. Leeds, MD
From the Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX.
Address correspondence and reprint requests to Dr. Bartlett D. Moore III, Division of Pediatrics (Box 87), University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030; e-mail: bmoore{at}mdanderson.org
OBJECTIVE: To determine characteristics of brain morphology in children and adolescents with neurofibromatosis type 1 and relate these characteristics to neuropsychological functioning.
BACKGROUND: Neurofibromatosis type 1 is associated with numerous CNS abnormalities and cognitive impairment. Abnormal high signal intensity visible on brain MRI, brain tumors, and macrocephaly are common. Research into links between neuroanatomic and cognitive features has been inconclusive.
METHODS: Fifty-two children and adolescents with neurofibromatosis type 1 were compared with 19 control subjects on several quantitative neuroanatomic and neuropsychological measures.
RESULTS: Total brain volume, especially gray matter, was significantly greater for neurofibromatosis type 1 subjects than the control subjects. Group differences in the ratio of gray matter to white matter were more prominent in younger than in older subjects. Volume of gray matter in the subjects with neurofibromatosis type 1 was related to their degree of learning disability. Corpus callosum size was significantly larger for subjects in the neurofibromatosis type 1 group, and diminished performance on measures of academic achievement and visual–spatial and motor skills were associated with greater regional corpus callosum size.
CONCLUSIONS: Neuroanatomic morphology and the developmental pattern of gray matter and white matter in subjects with neurofibromatosis type 1 differed from in control subjects. Some of these differences are related to the neuropsychological status of the neurofibromatosis type 1 group. We propose that delayed developmental apoptosis results in macrocephaly and a delay in the development of appropriate neuronal connections in children with neurofibromatosis type 1. We further propose that these morphologic delays are related to the cognitive profile of neurofibromatosis type 1.
Key words: Neurofibromatosis—Brain volume—Neuropsychology—Children
This article has been cited by other articles:
|
|
|
|
 
P. Nopoulos, V. A. Magnotta, A. Mikos, H. Paulson, N. C. Andreasen, and J. S. Paulsen
Morphology of the Cerebral Cortex in Preclinical Huntington's Disease
Am J Psychiatry,
September 1, 2007;
164(9):
1428 - 1434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.L. Zamboni, T. Loenneker, E. Boltshauser, E. Martin, and K.A. Il'yasov
Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol.,
April 1, 2007;
28(4):
773 - 776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Greenwood, L. A. Tupler, J. K. Whitt, A. Buu, C. B. Dombeck, A. G. Harp, M. E. Payne, J. D. Eastwood, K. R. R. Krishnan, and J. R. MacFall
Brain Morphometry, T2-Weighted Hyperintensities, and IQ in Children With Neurofibromatosis Type 1
Arch Neurol,
December 1, 2005;
62(12):
1904 - 1908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Feldmann, J. Denecke, M. Grenzebach, G. Schuierer, and J. Weglage
Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Neurology,
December 23, 2003;
61(12):
1725 - 1728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Billingsley, E. F. Jackson, J. M. Slopis, P. R. Swank, S. Mahankali, and B. D. Moore
Functional Magnetic Resonance Imaging of Phonologic Processing in Neurofibromatosis 1
J Child Neurol,
November 1, 2003;
18(11):
731 - 740.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Raine, T. Lencz, K. Taylor, J. B. Hellige, S. Bihrle, L. Lacasse, M. Lee, S. Ishikawa, and P. Colletti
Corpus Callosum Abnormalities in Psychopathic Antisocial Individuals
Arch Gen Psychiatry,
November 1, 2003;
60(11):
1134 - 1142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.L. Hyman, D.S. Gill, E.A. Shores, A. Steinberg, P. Joy, S.V. Gibikote, and K.N. North
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1
Neurology,
April 8, 2003;
60(7):
1139 - 1145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Schrimsher, R. L. Billingsley, E. F. Jackson, and B. D. Moore
Caudate Nucleus Volume Asymmetry Predicts Attention-Deficit Hyperactivity Disorder (ADHD) Symptomatology in Children
J Child Neurol,
December 1, 2002;
17(12):
877 - 884.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L.E. Cutting, K.L. Cooper, C.W. Koth, S.H. Mostofsky, W.R. Kates, M.B. Denckla, and W.E. Kaufmann
Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD
Neurology,
November 12, 2002;
59(9):
1388 - 1394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. North, S. Hyman, and B. Barton
Review Article : Cognitive Deficits in Neurofibromatosis 1
J Child Neurol,
August 1, 2002;
17(8):
605 - 612.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. L. Billingsley, G. W. Schrimsher, E. F. Jackson, J. M. Slopis, and B. D. Moore III
Significance of Planum Temporale and Planum Parietale Morphologic Features in Neurofibromatosis Type 1
Arch Neurol,
April 1, 2002;
59(4):
616 - 622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K. Pivnick
Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
AJNR Am. J. Neuroradiol.,
May 1, 2001;
22(5):
810 - 817.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Heumann, C. Goemans, D. Bartsch, K. Lingenhohl, P. C. Waldmeier, B. Hengerer, P. R. Allegrini, K. Schellander, E. F. Wagner, T. Arendt, et al.
Transgenic Activation of Ras in Neurons Promotes Hypertrophy and Protects from Lesion-Induced Degeneration
J. Cell Biol.,
December 25, 2000;
151(7):
1537 - 1548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
